Key statistics
As of last trade Incyte Corp (INCY:NSQ) traded at 71.77, -14.51% below its 52-week high of 83.95, set on Nov 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 70.43 |
---|---|
High | 71.91 |
Low | 70.33 |
Bid | 71.78 |
Offer | 71.86 |
Previous close | 70.39 |
Average volume | 3.13m |
---|---|
Shares outstanding | 192.65m |
Free float | 188.70m |
P/E (TTM) | 502.97 |
Market cap | 13.56bn USD |
EPS (TTM) | 0.14 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 16:36 GMT.
More ▼
- Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
- Incyte to Present at Upcoming Investor Conference
- Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Incyte to Present at Upcoming Investor Conferences
- Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
- Incyte Named One of Top 5 Companies on Science Magazine’s 2024 Top Employers List
- Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program
- Incyte to Report Third Quarter Financial Results
- Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
More ▼